Cambridge, UK, 11 December 2018: IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, announced its Founder and Chief Executive Officer, John McCafferty was invited to attend the Nobel Prize Award Ceremony in recognition of his pivotal contribution to the development of antibody phage display technology. The event, held in Stockholm, Sweden on 10th December, celebrated the 2018 Nobel Laureates and the success of phage display technology in modern drug discovery and development, which the Royal Swedish Academy of Sciences recognised in this year’s…

Sandwich, Kent, UK, December 10th 2018 - Discovery Park - and some of the businesses driving its success - will use one of the UK’s leading science events to showcase why it remains the perfect location for science companies looking to grow and collaborate. It will be attending Genesis 2018 with several of its life sciences tenants, showcasing their activities and discussing its plans for the future development of the Park.  Discovery Park is a thriving part of South East England’s life science community with high quality laboratory, office and manufacturing space, access to local…

PRINCETON, NJ – Dec. 5, 2018 – Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced the launch of its BaseCase Toolkits, an add-on to BaseCase Interactive which helps pharmaceutical and medical device field representatives better manage and utilize their resources for use during customer presentations. BaseCase Toolkits allows interactive tools – such as mobile apps – to be bundled together with other assets – such as product safety and efficacy data, and marketing assets – into user-friendly, highly-…

AMSBIO introduces ALiCE® - a new high yield cell-free protein expression system.  Cell-free protein expression (CFPE) is today used by protein chemists to quickly produce small amounts of proteins when screening DNA libraries. However current technologies are limited and there is a need for higher protein expression yields.  ALiCE® is a unique eukaryotic system, which yields an unprecedented 3 mg/ml of protein in batch mode. Even prokaryotic systems, which generally can only handle easy-to-express proteins, only get at their best 1 mg/ml protein in batch mode. These higher…

PRINCETON, NJ – Nov. 28, 2018 – Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced the launch of version 2.3 of its Trial Simulator software to help drug developers improve clinical trial design, resulting in greater likelihood of trial success. By allowing users to model and simulate different clinical trial scenarios, Certara’s Trial Simulator® allows them to identify and assess risks and preview the range of expected results before millions of R&D dollars are spent and human subjects are exposed to…

LOUGHBOROUGH, England (Nov. 26, 2018) – Activate Science, an annual event series organised by Thermo Fisher Scientific and attended by laboratory personnel across Europe, reached delegates at 36 customer sites in 2018. Emily Quinton, European Marketing Communications Manager, commented: “Activate Science has reached nearly 3,300 delegates in 10 European countries this year and provides a valuable opportunity to network and experience the latest innovations in laboratory products hands-on at customer sites.” Activate Science events are aimed at all laboratory personnel, including anyone who…

Air Liquide is pleased to announce their new site at Waterbeach in Cambridge. In order to get closer to our customers and provide the service you require we are now closer than ever to your business. - Expert support in Speciality and Industrial gas applications - Fast delivery from stock - All ranges of equipment and design assistance Email: john.pritchard@airliquide.com Tel: 07970 234332 Contact us to find out more: uk-sg-sales@airliquide.com 0845 757 3143 Listening to you, Working with you, Supporting you, GROWING TOGETHER.

AMSBIO announces that induced pluripotent stem (iPS) cell expert - Dr Masato Nakagawa from the Nobel Prize winning Yamanaka Lab** at the Centre for iPS Cell Research and Application, Kyoto University, Japan will give 3 talks in the UK on the 10th and 11th December 2018.Appearing at the Wellcome Genome Campus (Cambridge), the MRC Centre for Regenerative Medicine (Edinburgh) and at Guys Hospital (London) - Dr Nakagawa will present a talk on how to obtain well-reprogrammed and uniform human iPSCs using a combination of efficient reprogramming systems with a …

Acquisition increases BioIVT’s supply of leukopaks, plasma and sera, and enhances its ability to support the in vitro diagnostic market Westbury, NY – Nov. 5, 2018 – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired Biological Specialty Corporation (BSC), a supplier of human blood products and components to the life sciences research community for more than 37 years. BSC is headquartered in Colmar, PA, with two additional FDA-registered donor centers in Allentown, PA and Reading, PA. “We are delighted that BSC…

Wickham Laboratories will be exhibiting at Pharmig’s 26th annual conference held on the 28th & 29th November at the Belfry Hotel, Nottingham. This year’s event will bring together an array of industry experts and regulators to discuss the latest research and findings within the pharmaceutical microbiology industry. The conference programme will include the following topics among others: • Water system biofilms • Uses and applications of microbiological culture media • Sterility assurance strategies • Aseptic manufacturing • Endotoxin testing • Fungal and bacterial cleanroom excursions •…